Deep Origin
PrivateLast Round
Grant
Mar 1, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Deep Origin operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a VC Round in March 2024.
Deep Origin is a biotechnology company that provides an AI-driven, physics-based software platform designed to accelerate early-stage drug research and development for biomedical scientists and engineers.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, ML Platforms
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deep Origin Comparables
Compare Deep Origin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fathom Therapeutics | 86% | |
| HTuO Biosciences | 82% | |
| DeepMirror | 78% |
For institutional investors. Book with your work email.
Deep Origin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2026 | ||||
| VC Round | Mar 13, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Deep Origin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advanced Research and Invention Agency | Grant |
| SmartGateVC | VC Round, Seed |
| Healthcare Equity Angels | VC Round |
| Formic Ventures | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
Involved in a program or initiative with ARPA-H.
- Mar 1, 2026
Secured $660K in grant funding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 14, 2026
Deep Origin Inc. partners with BioAge Labs, Inc. on a multi-target AI-driven drug discovery collaboration in California on Oct. 14th '26, with computationally identified small-molecule hits against a first target validated in BioAge Labs, Inc.'s laboratory.
For institutional investors. Book with your work email.
Deep Origin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Deep Origin's valuation, stock price, and market status.
Is Deep Origin a public or private company?
Deep Origin is a private company.
What is the current stock price of Deep Origin?
Deep Origin is a private company, so its shares have no public market price. Caplight tracks Deep Origin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deep Origin worth (valuation)?
Valuation information for Deep Origin is not publicly available.
Can I buy Deep Origin stock?
Deep Origin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deep Origin's last funding round?
Deep Origin's most recent funding round was Grant on March 1, 2026.
Who are the main investors in Deep Origin?
Key investors in Deep Origin include Formic Ventures.
Will Deep Origin IPO soon?
No public IPO plans have been announced for Deep Origin.
How can I track Deep Origin secondary market activity?
Caplight tracks bids, offers, and trades in Deep Origin's shares on secondary markets.